New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case–control study in UK general practice

BACKGROUND: Evidence from clinical trial populations suggests low-dose aspirin reduces the risk of colorectal cancer (CRC). Part of this reduction in risk might be due to protection against metastatic disease. METHODS: We investigated the risk of CRC among new-users of low-dose aspirin (75–300 mg),...

Descripción completa

Detalles Bibliográficos
Autores principales: García Rodríguez, Luis A., Soriano-Gabarró, Montse, Bromley, Susan, Lanas, Angel, Cea Soriano, Lucía
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590216/
https://www.ncbi.nlm.nih.gov/pubmed/28882113
http://dx.doi.org/10.1186/s12885-017-3594-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590216/
https://www.ncbi.nlm.nih.gov/pubmed/28882113
http://dx.doi.org/10.1186/s12885-017-3594-9

Ejemplares similares